In a new job - January 23, 2026
Abera Bioscience strengthens its team
The company is in an intensive development phase in which several vaccine candidates are being advanced in parallel towards clinical development. To ensure continued high execution capacity and long-term competence, the company is now strengthening its organisation through recruitment.
In a new job - January 16, 2026
Bioretec appoints new Chief Financial Officer
Bioretec appoints Tuukka Paavola as Chief Financial Officer.
In a new job - January 9, 2026
AstraZeneca appoints Head of Investor Relations
AstraZeneca’s new head of Investor Relations, Joris Silon, succeeds Andy Barnett on 1 March 2026, and will be based in Cambridge, UK.
In a new job - January 8, 2026
Q-linea announces changes in US commercial leadership
Q-linea has announces that Jim Kathrein will step down as VP US Commercial Operations.
In a new job - January 6, 2026
She is the new CEO of Alvotech
Alvotech has announced key senior leadership changes following a planned succession process.
In a new job - January 6, 2026
Nykode nominates new Chair of the Board
Nykode Therapeutics has announced the proposed election of Dr. Barbara Krebs-Pohl as the new Chair of the Board, succeeding Susanne Stuffers, who has served as interim Chair since April 2025.
